Article: AirInSpace Receives FDA Clearance to Market an Advanced Mobile Device That Captures and Inactivates Biological Particles from the Air for Medical Purposes.

Company also appoints Wade Tetsuka as President of its U.S. operations and establishes headquarters in Sterling, Virginia

Company seeks to penetrate U.S. hospital market with novel and patented PlasmairT2006 by AirInSpace mobile unit

WASHINGTON -- AirInSpace, the leading supplier in the French market of mobile devices that capture and inactivate harmful and resistant biological particles from the air, announced today that it has received FDA clearance to market its PlasmairT2006 by AirInSpace mobile system as a medical device. The same remarkable technology that has been protecting astronauts aboard the International Space Station (ISS) since 2000 ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!